72
G. Murtaza et al.
References
1. Drain PK, Hyle EP, Noubary F et al (2014) Diagnostic point-of-care tests in resource-limited
settings. Lancet Infect Dis 14:239–249
2. Ehrmeyer SS, Laessig RH (2007) Point-of-care testing, medical error, and patient safety: a
2007 assessment. Clin Chem Lab Med 45:766–773
3. Pai NP, Vadnais C, Denkinger C et al (2012) Point-of-care testing for infectious diseases:
diversity, complexity, and barriers in low- and middle-income countries. PLoS Med 9. https://
doi.org/10.1371/journal.pmed.1001306
4. Zhu G, Chen X (2018) Aptamer-based targeted therapy. Adv Drug Deliv Rev. https://doi.org/
10.1016/j.addr.2018.08.005
5. Kaur H (2018) Recent developments in cell-SELEX technology for aptamer selection. Biochim
Biophys Acta—Gen. Subj 1862:2323–2329
6. Reid R, Chaterjee B, Das S et al (2020) Application of aptamers as molecular recognition
elements in lateral flow assays for analytical applications. Anal Biochem 113574. https://doi.
org/10.1016/j.ab.2020.113574
7. Chen A, Yang S (2015) Replacing antibodies with aptamers in lateral flow immunoassay.
Biosens Bioelectron 71:230–242
8. Jia M, Mao Y, Wu C et al (2019) A platform for primary tumor origin identification of circulating
tumor cells via antibody cocktail-based in vivo capture and specific aptamer-based multicolor
fluorescence imaging strategy. Anal Chim Acta 1082:136–145. https://doi.org/10.1016/j.aca.
2019.07.051
9. Esposito CL, Nuzzo S, Catuogno S et al (2018) STAT3 gene silencing by Aptamer-siRNA
Chimera as selective therapeutic for glioblastoma. Mol Ther—Nucleic Acids 10:398–411.
https://doi.org/10.1016/j.omtn.2017.12.021
10. Yu Y, Liang C, Lv Q et al (2016) Molecular selection, modification and development of
therapeutic oligonucleotide aptamers. Int J Mol Sci 17:1–19. https://doi.org/10.3390/ijms17
030358
11. Chang CC, Chen CY, Chuang TL et al (2016) Aptamer-based colorimetric detection of proteins
using a branched DNA cascade amplification strategy and unmodified gold nanoparticles.
Biosens Bioelectron 78:200–205. https://doi.org/10.1016/j.bios.2015.11.051
12. Hanif A, Farooq R, Rehman MU et al (2019) Aptamer based nanobiosensors: promising
healthcare devices. Saudi Pharm. J. 27:312–319
13. Hu J, Xiao K, Jin B et al (2019) Paper-based point-of-care test with xeno nucleic acid probes.
Biotechnol Bioeng 116:2764–2777
14. Ruscito A, Mcconnell EM, Koudrina A et al (2017) In vitro selection and characterization of
DNA aptamers to a small molecule target, 9:233–268
15. Sundararaj N, Kalagatur NK, Mudili V et al (2019) Isolation and identification of enterotoxigenic Staphylococcus aureus isolates from Indian food samples: evaluation of in-house developed aptamer linked sandwich ELISA (ALISA) method. J Food Sci Technol 56:1016–1026.
https://doi.org/10.1007/s13197-019-03568-1
16. Alizadeh N, Memar MY, Mehramuz B et al (2018) Current advances in aptamer-assisted
technologies for detecting bacterial and fungal toxins. J Appl Microbiol 124:644–651. https://
doi.org/10.1111/jam.13650
17. Angel A (2020) Discovery of single-stranded DNA aptamers for the detection of ranavirus.
Theses, Dissertations and Culminating Projects 477. https://digitalcommons.montclair.edu/
etd/477
18. Sett A, Borthakur BB, Sharma JD et al (2017) DNA aptamer probes for detection of estrogen
receptor α positive carcinomas. Transl Res 183:104–120.e2. https://doi.org/10.1016/j.trsl.2016.
12.008
19. Lee K, Ahn J, Lee S et al (2015) Aptamer-based sandwich assay and its clinical outlooks for
detecting lipocalin-2 in Hepatocellular Carcinoma (HCC). Sci Rep 5:10897. https://doi.org/
10.1038/srep10897
G. Murtaza et al.
References
1. Drain PK, Hyle EP, Noubary F et al (2014) Diagnostic point-of-care tests in resource-limited
settings. Lancet Infect Dis 14:239–249
2. Ehrmeyer SS, Laessig RH (2007) Point-of-care testing, medical error, and patient safety: a
2007 assessment. Clin Chem Lab Med 45:766–773
3. Pai NP, Vadnais C, Denkinger C et al (2012) Point-of-care testing for infectious diseases:
diversity, complexity, and barriers in low- and middle-income countries. PLoS Med 9. https://
doi.org/10.1371/journal.pmed.1001306
4. Zhu G, Chen X (2018) Aptamer-based targeted therapy. Adv Drug Deliv Rev. https://doi.org/
10.1016/j.addr.2018.08.005
5. Kaur H (2018) Recent developments in cell-SELEX technology for aptamer selection. Biochim
Biophys Acta—Gen. Subj 1862:2323–2329
6. Reid R, Chaterjee B, Das S et al (2020) Application of aptamers as molecular recognition
elements in lateral flow assays for analytical applications. Anal Biochem 113574. https://doi.
org/10.1016/j.ab.2020.113574
7. Chen A, Yang S (2015) Replacing antibodies with aptamers in lateral flow immunoassay.
Biosens Bioelectron 71:230–242
8. Jia M, Mao Y, Wu C et al (2019) A platform for primary tumor origin identification of circulating
tumor cells via antibody cocktail-based in vivo capture and specific aptamer-based multicolor
fluorescence imaging strategy. Anal Chim Acta 1082:136–145. https://doi.org/10.1016/j.aca.
2019.07.051
9. Esposito CL, Nuzzo S, Catuogno S et al (2018) STAT3 gene silencing by Aptamer-siRNA
Chimera as selective therapeutic for glioblastoma. Mol Ther—Nucleic Acids 10:398–411.
https://doi.org/10.1016/j.omtn.2017.12.021
10. Yu Y, Liang C, Lv Q et al (2016) Molecular selection, modification and development of
therapeutic oligonucleotide aptamers. Int J Mol Sci 17:1–19. https://doi.org/10.3390/ijms17
030358
11. Chang CC, Chen CY, Chuang TL et al (2016) Aptamer-based colorimetric detection of proteins
using a branched DNA cascade amplification strategy and unmodified gold nanoparticles.
Biosens Bioelectron 78:200–205. https://doi.org/10.1016/j.bios.2015.11.051
12. Hanif A, Farooq R, Rehman MU et al (2019) Aptamer based nanobiosensors: promising
healthcare devices. Saudi Pharm. J. 27:312–319
13. Hu J, Xiao K, Jin B et al (2019) Paper-based point-of-care test with xeno nucleic acid probes.
Biotechnol Bioeng 116:2764–2777
14. Ruscito A, Mcconnell EM, Koudrina A et al (2017) In vitro selection and characterization of
DNA aptamers to a small molecule target, 9:233–268
15. Sundararaj N, Kalagatur NK, Mudili V et al (2019) Isolation and identification of enterotoxigenic Staphylococcus aureus isolates from Indian food samples: evaluation of in-house developed aptamer linked sandwich ELISA (ALISA) method. J Food Sci Technol 56:1016–1026.
https://doi.org/10.1007/s13197-019-03568-1
16. Alizadeh N, Memar MY, Mehramuz B et al (2018) Current advances in aptamer-assisted
technologies for detecting bacterial and fungal toxins. J Appl Microbiol 124:644–651. https://
doi.org/10.1111/jam.13650
17. Angel A (2020) Discovery of single-stranded DNA aptamers for the detection of ranavirus.
Theses, Dissertations and Culminating Projects 477. https://digitalcommons.montclair.edu/
etd/477
18. Sett A, Borthakur BB, Sharma JD et al (2017) DNA aptamer probes for detection of estrogen
receptor α positive carcinomas. Transl Res 183:104–120.e2. https://doi.org/10.1016/j.trsl.2016.
12.008
19. Lee K, Ahn J, Lee S et al (2015) Aptamer-based sandwich assay and its clinical outlooks for
detecting lipocalin-2 in Hepatocellular Carcinoma (HCC). Sci Rep 5:10897. https://doi.org/
10.1038/srep10897